We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+4.33%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$59B
AUM Growth
-$15.3B
(-21%)
Cap. Flow
-$17.5B
Cap. Flow
% of AUM
-29.66%
Top 10 Holdings %
Top 10 Hldgs %
23.25%
Holding
2,070
New
257
Increased
660
Reduced
658
Closed
198
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Crown Castle
CCI
|
+$593M |
| 2 |
American Tower
AMT
|
+$295M |
| 3 |
KLA
KLAC
|
+$242M |
| 4 |
Ingersoll Rand
IR
|
+$149M |
| 5 |
TotalEnergies
TTE
|
+$129M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.34B |
| 2 |
Apple
AAPL
|
+$1.27B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.04B |
| 4 |
Amazon
AMZN
|
+$999M |
| 5 |
Applied Materials
AMAT
|
+$612M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.74% |
| 2 | Financials | 12.95% |
| 3 | Industrials | 12.91% |
| 4 | Healthcare | 10.97% |
| 5 | Consumer Discretionary | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
LeMaitre Vascular
LMAT
$1.85B
| $3.68M | 0.01% |
45,406
+1,546
| +4% | +$133K |
|
652
Brighthouse Financial
BHF
$3.57B
| $3.68M | 0.01% |
56,752
-60,094
| -51% | -$3.53M |
|
653
Ionis Pharmaceuticals
IONS
$9.06B
| $3.67M | 0.01% |
46,402
-17,389
| -27% | -$1.31M |
|
654
Healthcare Services Group
HCSG
$1.51B
| $3.66M | 0.01% |
191,600
-7,139
| -4% | -$128K |
|
655
Preformed Line Products
PLPC
$2.25B
| $3.65M | 0.01% |
17,668
-551
| -3% | -$117K |
|
|
MPLT
656
MapLight Therapeutics
MPLT
$602M
| $3.64M | 0.01% |
+207,494
| New | +$3.48M |
|
657
TeraWulf
WULF
$8.79B
| $3.64M | 0.01% |
+317,187
| New | +$4.25M |
|
658
Vontier
VNT
$4.97B
| $3.61M | 0.01% |
97,140
-34,074
| -26% | -$1.3M |
|
659
Bank of N.T. Butterfield & Son
NTB
$2.44B
| $3.61M | 0.01% |
72,455
+2,600
| +4% | +$120K |
|
660
Centene
CNC
$31.7B
| $3.58M | 0.01% |
87,117
-15,007
| -15% | -$562K |
|
661
AES
AES
$10.5B
| $3.58M | 0.01% |
249,945
-501,826
| -67% | -$7.07M |
|
662
N-able
NABL
$917M
| $3.58M | 0.01% |
478,885
-2,165
| -0.5% | -$16.5K |
|
663
Ingredion
INGR
$6.49B
| $3.57M | 0.01% |
32,382
-56,104
| -63% | -$6.33M |
|
664
Bloom Energy
BE
$67.4B
| $3.56M | 0.01% |
+41,000
| New | +$4.31M |
|
665
Xenon Pharmaceuticals
XENE
$6.24B
| $3.53M | 0.01% |
+78,663
| New | +$3.3M |
|
666
TPG
TPG
$7.78B
| $3.5M | 0.01% |
54,763
+22,244
| +68% | +$1.31M |
|
667
Roblox
RBLX
$25.7B
| $3.49M | 0.01% |
43,074
-4,252
| -9% | -$451K |
|
668
iShares China Large-Cap ETF
FXI
$4.29B
| $3.45M | 0.01% |
90,156
-26,929
| -23% | -$1.07M |
|
669
Yext
YEXT
$558M
| $3.45M | 0.01% |
427,867
+354,143
| +480% | +$2.98M |
|
670
iShares 20+ Year Treasury Bond ETF
TLT
$41.6B
| $3.45M | 0.01% |
39,527
-1,704
| -4% | -$152K |
|
671
Schwab US Large- Cap ETF
SCHX
$73.9B
| $3.42M | 0.01% |
126,942
| – | – |
|
672
Graphic Packaging
GPK
$3.51B
| $3.41M | 0.01% |
226,130
-12,599
| -5% | -$207K |
|
673
OneSpan
OSPN
$598M
| $3.4M | 0.01% |
264,828
+2,197
| +0.8% | +$29.8K |
|
674
Ironwood Pharmaceuticals
IRWD
$701M
| $3.37M | 0.01% |
+1,000,445
| New | +$2.6M |
|
675
TAL Education Group
TAL
$6.91B
| $3.35M | 0.01% |
+307,150
| New | +$3.49M |
|
Similar funds
QCM
Lazard Asset Management's Q4 2025 Portfolio in Review
As of Q4 2025, Lazard Asset Management held 2,070 positions worth $59B, down 21% from $74.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Lazard Asset Management withdrew a net $17.5B in Q4 2025, closing 198 positions and reducing 658 holdings. Its most notable exit was Henry Schein, an estimated $30.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Financials and Industrials.
Against the trend, Lazard Asset Management opened a new position in Ingersoll Rand worth $149M.
- Lazard Asset Management's largest Q4 2025 buy was Ingersoll Rand: 1,884,586 shares worth $149M.
- Lazard Asset Management added most to Crown Castle in Q4 2025, an estimated $593M increase.
- Lazard Asset Management's biggest Q4 2025 reduction was Microsoft, cutting an estimated $1.34B.
- Lazard Asset Management fully exited Henry Schein in Q4 2025, selling an estimated $30.7M.
- Lazard Asset Management's ten largest holdings make up 23% of its $59B portfolio in Q4 2025.
- Lazard Asset Management opened 257 new positions and closed 198 in Q4 2025.
- Lazard Asset Management's portfolio value fell 21% quarter-over-quarter to $59B.
Based on Lazard Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.